X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (208) 208
tmc125 etravirine (207) 207
placebo-controlled trial (189) 189
double-blind (184) 184
index medicus (181) 181
experienced hiv-1-infected patients (163) 163
hiv infections - drug therapy (152) 152
infectious diseases (128) 128
efficacy (119) 119
pharmacology & pharmacy (108) 108
safety (106) 106
male (99) 99
female (94) 94
hiv-1 - drug effects (91) 91
etravirine (89) 89
hiv (85) 85
adult (83) 83
virology (80) 80
hiv infections - virology (79) 79
anti-hiv agents - therapeutic use (68) 68
immunology (64) 64
middle aged (62) 62
antiviral agents (58) 58
treatment outcome (58) 58
anti-hiv agents - pharmacology (57) 57
antiretroviral therapy (57) 57
drug resistance, viral (55) 55
hiv-1 - genetics (54) 54
tmc125 (54) 54
anti-hiv agents - administration & dosage (47) 47
drug therapy (47) 47
pyridazines - administration & dosage (47) 47
microbiology (46) 46
hiv infection (45) 45
mutation (44) 44
pyridazines - therapeutic use (44) 44
viral load (44) 44
antiretroviral drugs (43) 43
drug resistance (43) 43
human immunodeficiency virus--hiv (43) 43
immunodeficiency-virus type-1 (43) 43
reverse transcriptase inhibitors - pharmacology (43) 43
anti-hiv agents - adverse effects (42) 42
reverse transcriptase inhibitors - therapeutic use (42) 42
hiv-1 (41) 41
resistance (41) 41
darunavir (40) 40
pyridazines - adverse effects (39) 39
pyridazines - pharmacology (39) 39
aids/hiv (37) 37
drug-resistance (37) 37
reverse-transcriptase inhibitors (37) 37
pyridazines - pharmacokinetics (34) 34
drug therapy, combination (32) 32
cd4 lymphocyte count (31) 31
protease inhibitors (31) 31
genotype (30) 30
hiv-1-infected patients (30) 30
raltegravir (30) 30
pharmacokinetics (29) 29
dosage and administration (28) 28
research (28) 28
hiv protease inhibitors - therapeutic use (26) 26
infection (26) 26
reverse transcriptase inhibitors - administration & dosage (26) 26
drug interactions (25) 25
drug resistance, viral - genetics (25) 25
efavirenz (25) 25
anti-hiv agents - pharmacokinetics (24) 24
hiv reverse transcriptase - antagonists & inhibitors (24) 24
reverse transcriptase inhibitors - pharmacokinetics (24) 24
clinical trials (23) 23
nevirapine (22) 22
therapy (22) 22
adolescent (21) 21
health aspects (21) 21
reverse transcriptase inhibitors - adverse effects (21) 21
ritonavir (21) 21
treatment failure (21) 21
aids (20) 20
hiv reverse transcriptase - genetics (20) 20
hiv-1 - isolation & purification (20) 20
analysis (19) 19
anti-hiv agents (19) 19
antiviral activity (19) 19
rilpivirine (19) 19
young adult (19) 19
dna polymerases (18) 18
hiv-1 - enzymology (18) 18
hiv-1 infection (18) 18
mutations (18) 18
non-nucleoside reverse transcriptase inhibitors (18) 18
raltegravir potassium (18) 18
sulfonamides - therapeutic use (18) 18
virus diseases (18) 18
chemistry, medicinal (17) 17
drug design (17) 17
hiv-infected patients (17) 17
nnrti (17) 17
resistant hiv-1 (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Reviews Drug Discovery, ISSN 1474-1776, 04/2008, Volume 7, Issue 4, pp. 287 - 288
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2009, Volume 49, Issue 9, pp. 1441 - 1449
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2009, Volume 48, Issue 8, pp. 1123 - 1128
Etravirine is the first next-generation nonnucleoside reverse-transcriptase inhibitor (NNRTI) that is approved for the treatment of HIV infection in patients... 
INFECTIOUS DISEASES | EFFICACY | SAFETY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | IMMUNOLOGY | DOUBLE-BLIND | INFECTION | PLACEBO-CONTROLLED TRIAL | Drugs | Enzymes | Human immunodeficiency virus--HIV | Pharmacology | Mutation | Metabolism | Virology
Journal Article
AUSTRALIAN PRESCRIBER, ISSN 0312-8008, 04/2009, Volume 32, Issue 2, pp. 53 - 54
Journal Article
by Katlama, Christine and Haubrich, Richard and Lalezari, Jacob and Lazzarin, Aiano and Mauga, José V and Molina, Jean-Michel and Schechter, Mauro and Peeters, Monika and Picchio, Gaston and Vingerhoets, Johan and Woodfall, Brian and de Smedt, Goedele and Ariza, H. A and Benetucci, J and Cahn, P and Calanni, L. M and Cassetti, I and Corral, J and David, D. O and Krolewiecki, A and Losso, M. H and Patterson, P and Teijeiro, R. A and Grinsztejn, B and da Cunha, C. A and Kallas, E. G and Netto, E. M and Pilotto, J. H and Suleiman, J and Timerman, A and Ballesteros, J and Northland, R and Alvilés Montoya, A. A and Herrera Martinez, G and Solano Chinchilla, A and Dupon, M and Livrozet, J. M and Morlat, P and Pialoux, G and Piketty, C and Poizot-Martin, I and Anade-Villanueva, J and Reyes-Terán, G and Sierra-Madero, J and Canton, A and Roiguez, A and Sosa, N and Morales Ramirez, J. O and Santana Bagur, J. L and Soto-Malave, R and Anekthananon, T and Mootsikapun, P and Ruxrungtham, K and Albrecht, M and Bellos, N and Bolan, R and Brachman, P and Brinson, C and Cruickshank, F and Elion, R and Fessel, W. J and Hawkins, T and Hodder, S and Hutcherson, P and Jefferson, T and Katner, H and Kinder, C and Kozal, M and Leider, J and Mills, T and McDonough, D and Mounzer, K and Nadler, J and Norris, D and O'Brien, W and Pierone, G and Raben, K and Rashbaum, B and Rawlings, M and Rodwick, B and Ruane, P and Sampson, J and Schrader, S and Scribner, A and Sension, M and Sweet, D and Wade, B and Wheeler, D and Wilkin, A and Wills, T and Wohlfeiler, M and Workowski, K and Chuah, J and Cooper, D and Eu, B and Hoy, J and Workman, C and Clumeck, N and Colebunders, R and Moutschen, M and ... and DUET-1 Study Grp and DUET-2 Study Grp and DUET-1, DUET-2 study groups
AIDS (London, England), ISSN 0269-9370, 2009, Volume 23, Issue 17, pp. 2289 - 2300
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2008, Volume 66, Issue 4, pp. 508 - 516
Journal Article
Journal Article
Journal Article